CJC-1295 DAC - OXYGENS LAB

CJC-1295 DAC is a research peptide supplied as a lyophilised vial intended for use in laboratory and investigational settings. It is used by adults who are exploring peptide-based protocols and want a longer‑acting growth hormone‑releasing hormone analogue. This page summarises what the product contains, how it is typically handled, and practical points to consider before use. It is not medical advice — consult a qualified healthcare professional before starting any peptide protocol.

At a glance

• Intended users: adults involved in research or under medical supervision; not for use by children.
• Key concern: investigational peptide supplied as powder for reconstitution.
• What’s included / size: 1 vial, 2000 mcg concentration (see vial label for exact quantity).
• Form & texture: a dry, white to off‑white lyophilised powder; reconstituted to a clear solution.
• Fragrance: none.
• Cruelty-free: not applicable to synthetic peptide preparations.

What it is

How to use

• Reconstitution: add bacteriostatic water to the vial following sterile technique. Typical reconstitution volumes reported in research contexts are 1 ml per vial, but follow the vial label and your clinician’s instructions.
• Administration routes: commonly administered subcutaneously or intramuscularly in research or clinical settings; use only sterile equipment and proper aseptic practice.
• Reported dosing examples: literature and practitioner reports vary; commonly cited schedules include 1 mg twice weekly or 2 mg once weekly. These are examples, not prescriptions — consult a healthcare professional to determine suitability and dosing.
• Safety note: always use under the guidance of a qualified practitioner. Do not attempt if you are unsure about dosing, injection technique, or contraindications.

Why it works

• CJC-1295 DAC — a modified peptide analogue used in investigational settings; its design extends circulation time compared with shorter‑acting analogues.
• Albumin‑binding modification — a chemical strategy that can prolong peptide half‑life in circulation, which is why it is used where a sustained effect is desired.
• Bacteriostatic water — diluent that helps maintain sterility when reconstituting the vial; does not alter the peptide’s sequence.

What to expect

• Responses vary between individuals. In research or monitored use, changes in measurable endpoints are typically tracked over several weeks; timelines differ according to protocol and individual factors.
• If you experience unexpected reactions after administration, stop use and seek medical advice promptly.

Good to know

• Not intended for use by pregnant or breastfeeding individuals; discuss risks with a clinician.
• Use only if you have appropriate clinical oversight and sterile technique training.
• Do not share syringes or reconstituted solution; discard needles and single‑use items safely.
• Stop use and consult a healthcare professional if irritation, infection at the injection site, or other concerning symptoms occur.

Ingredients (INCI)

See packaging for the full INCI. Primary labelled contents typically include the synthetic peptide (CJC-1295 DAC) and instructions for reconstitution with bacteriostatic water.

Storage & care

• Store the unopened vial refrigerated at 2°C–8°C.
• After reconstitution, follow the stability guidance on the vial or packaging and use within the recommended timeframe.
• Avoid contamination: use sterile syringes, needles and handling procedures when preparing and administering the product.

Shipping & returns

Fast, tracked delivery nationwide (2–5 business days) in South Africa. Returns and refunds are subject to our store policy — contact customer support if you have concerns about your order.

If you’re unsure whether this product is right for your protocol, speak to a qualified healthcare practitioner before proceeding.